Jefferies Reiterates Buy on Allscripts (MDRX) Following Investor Day
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
Go back to Jefferies Reiterates Buy on Allscripts (MDRX) Following Investor Day
March 22, 2017 7:34 AM EDT
Cantor Fitzgerald reiterated a Neutral rating and $13.00 price target on Allscripts (NASDAQ: MDRX) following an analyst meeting. The company indicated that its customer satisfaction scores among US acute care hospitals improved by 16% in 2016 vs. 2015 levels. MDRX is also leveraging its investments in dbMotion... More
March 22, 2017 6:09 AM EDT
Cowen analyst Charles Rhyee raised its price target on Allscripts (NASDAQ: MDRX) to $13.00 (from $12.00) while maintaining a Market Perform rating, suggesting an incrementally positive outlook on the company following the Investor Conference.
Rhyee comments, "Following the Investor Conference, we are incrementally... More
March 20, 2017 8:52 AM EDT
Allscripts (NASDAQ: MDRX) April call option implied volatility is at 30, May is at 31; compared to its 52-week range of 25 to 46 into a company hosted investor day on March 21.
...
More
